These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2592825)

  • 1. [Clinical experience of a totally implantable venous catheter for gynecologic cancer patients].
    Dozono H; Kamiwatari M; Ikeda S; Shinmura R; Miwa K; Nagata Y; Unoki Y; Arima N
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Dec; 41(12):2023-5. PubMed ID: 2592825
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term experience with a totally implanted catheter system in gynecologic oncologic patients.
    Koonings PP; Given FT
    J Am Coll Surg; 1994 Feb; 178(2):164-6. PubMed ID: 8173727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with the intravenous totally implanted port in patients with gynecologic malignancies.
    Nelson BE; Mayer AR; Tseng PC; Schwartz PE
    Gynecol Oncol; 1994 Apr; 53(1):98-102. PubMed ID: 8175028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients.
    Gleeson NC; Fiorica JV; Mark JE; Pinelli DM; Hoffman MS; Roberts WS; Cavanagh D
    Gynecol Oncol; 1993 Dec; 51(3):372-6. PubMed ID: 8112648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' attitudes to totally implantable venous access port systems for gynecological or breast malignancies.
    Kreis H; Loehberg CR; Lux MP; Ackermann S; Lang W; Beckmann MW; Fasching PA
    Eur J Surg Oncol; 2007 Feb; 33(1):39-43. PubMed ID: 17029869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with an implantable venous access system for chemotherapy.
    Pettengell R; Davies AJ; Harvey VJ
    N Z Med J; 1991 Jul; 104(915):284-5. PubMed ID: 1852329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal chemotherapy via the Groshong catheter in the patient with gynecologic cancer.
    Hrozenick SP; Ness EA
    Oncol Nurs Forum; 1991; 18(7):1245-6. PubMed ID: 1945971
    [No Abstract]   [Full Text] [Related]  

  • 8. Peripheral infusion ports for central venous access in patients with gynecologic malignancies.
    Cunningham MJ; Collins MB; Kredentser DC; Malfetano JH
    Gynecol Oncol; 1996 Mar; 60(3):397-9. PubMed ID: 8774645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A peripherally implanted permanent central venous access device.
    Morris P; Buller R; Kendall S; Anderson B
    Obstet Gynecol; 1991 Dec; 78(6):1138-42. PubMed ID: 1945224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infusion pumps and subcutaneously implantable catheter systems as an aid in the ambulatory care of tumor patients].
    Ludwig CU; Obrecht JP
    Ther Umsch; 1989 Oct; 46(10):709-14. PubMed ID: 2814907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of Groshong central venous catheters on a gynecologic oncology service.
    Holloway RW; Orr JW
    Gynecol Oncol; 1995 Feb; 56(2):211-7. PubMed ID: 7896188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of totally implantable venous system in cancer patients. Surgical technique and initial clinical experience].
    Ferranti F; Chichi GL; Mazzola L; Triveri P; Palmieri RM
    G Chir; 2002 May; 23(5):225-8. PubMed ID: 12228978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insertion of Groshong central venous catheters utilizing fluoroscopic techniques.
    Burnett AF; Lossef SV; Barth KH; Grendys EC; Johnson JC; Barter JF; Barnes WA
    Gynecol Oncol; 1994 Jan; 52(1):69-73. PubMed ID: 8307504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Uncommon complication of the use of implantable chambers in oncology].
    Coton T; Bonnet D; Pinot JJ; Rey P; Lemesle L; Bernady A; Eskandari J; Cador L; De Muizon H
    Rev Pneumol Clin; 1995; 51(6):351-3. PubMed ID: 8746026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Totally implantable catheters. Experience at the University Hospital Center Vaudois from March 1984 to December 1987].
    Amrein E; Leyvraz S; Genton A; Pettavel J; Beck D
    Helv Chir Acta; 1989 Jun; 56(1-2):289-93. PubMed ID: 2777615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial regarding use of modified femoral vein approach as method for implanting a totally implantable access port in patients with synchronous bilateral mastectomies (Chen et al.).
    Wanebo HJ
    J Surg Oncol; 2008 Sep; 98(3):147. PubMed ID: 18704913
    [No Abstract]   [Full Text] [Related]  

  • 17. [A total subcutaneously implantable venous catheter system. 4 years' experience in cancer patients].
    Ludwig R; Ludwig CU; Laffer U; Stoll HR; Obrecht JP
    Schweiz Med Wochenschr; 1988 Mar; 118(9):305-8. PubMed ID: 3358106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications related to indwelling caval catheters on a gynecologic oncology service.
    Silver DF; Hempling RE; Recio FO; Piver MS; Eltabbakh GH
    Gynecol Oncol; 1998 Sep; 70(3):329-33. PubMed ID: 9790783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraarterial pelvic infusion chemotherapy in advanced gynecologic cancer.
    Lifshitz S; Railsback LD; Buchsbaum HJ
    Obstet Gynecol; 1978 Oct; 52(4):476-80. PubMed ID: 309571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
    Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
    Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.